ITMI20021399A0 - CYCLOXYGENASE INHIBITORS 2 - Google Patents

CYCLOXYGENASE INHIBITORS 2

Info

Publication number
ITMI20021399A0
ITMI20021399A0 IT2002MI001399A ITMI20021399A ITMI20021399A0 IT MI20021399 A0 ITMI20021399 A0 IT MI20021399A0 IT 2002MI001399 A IT2002MI001399 A IT 2002MI001399A IT MI20021399 A ITMI20021399 A IT MI20021399A IT MI20021399 A0 ITMI20021399 A0 IT MI20021399A0
Authority
IT
Italy
Prior art keywords
cycloxygenase inhibitors
cycloxygenase
inhibitors
Prior art date
Application number
IT2002MI001399A
Other languages
Italian (it)
Inventor
Giancarlo Santus
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Priority to IT2002MI001399A priority Critical patent/ITMI20021399A1/en
Publication of ITMI20021399A0 publication Critical patent/ITMI20021399A0/en
Priority to AU2003238042A priority patent/AU2003238042A1/en
Priority to PCT/EP2003/006651 priority patent/WO2004000300A1/en
Publication of ITMI20021399A1 publication Critical patent/ITMI20021399A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2002MI001399A 2002-06-25 2002-06-25 CYCLOOXYGENASE INHIBITORS 2 ITMI20021399A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2002MI001399A ITMI20021399A1 (en) 2002-06-25 2002-06-25 CYCLOOXYGENASE INHIBITORS 2
AU2003238042A AU2003238042A1 (en) 2002-06-25 2003-06-24 Cyclooxygenase-2 inhibitors
PCT/EP2003/006651 WO2004000300A1 (en) 2002-06-25 2003-06-24 Cyclooxygenase-2 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001399A ITMI20021399A1 (en) 2002-06-25 2002-06-25 CYCLOOXYGENASE INHIBITORS 2

Publications (2)

Publication Number Publication Date
ITMI20021399A0 true ITMI20021399A0 (en) 2002-06-25
ITMI20021399A1 ITMI20021399A1 (en) 2003-12-29

Family

ID=11450085

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI001399A ITMI20021399A1 (en) 2002-06-25 2002-06-25 CYCLOOXYGENASE INHIBITORS 2

Country Status (3)

Country Link
AU (1) AU2003238042A1 (en)
IT (1) ITMI20021399A1 (en)
WO (1) WO2004000300A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003248642A1 (en) 2002-06-11 2003-12-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AU2003247622A1 (en) 2002-06-27 2004-01-19 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
WO2004004648A2 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
CA2493082A1 (en) 2002-07-26 2004-02-05 Merck Frosst Canada & Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
US7632866B2 (en) 2002-10-21 2009-12-15 Ramot At Tel Aviv University Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
DE602004021238D1 (en) 2003-03-05 2009-07-09 Merck Frosst Company NITROGEN MONOXIDE RELEASING PRODRUGS OF DIARYL-2- (5H) FURANOES AS INHIBITORS OF CYCLOOXYGENASE-2
EP1789091B1 (en) 2004-08-26 2010-08-25 Piramal Life Sciences Limited Prodrugs containing novel bio-cleavable linkers
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
US7521435B2 (en) 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
JP2009516719A (en) * 2005-11-23 2009-04-23 ニコックス エス エイ Salicylic acid derivative
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
CA2691446C (en) 2007-06-04 2021-07-06 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
WO2009037705A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation
CN101868443A (en) 2007-09-20 2010-10-20 特拉维夫大学拉莫特有限公司 N-phenyl anthranilic acid derivatives and uses thereof
TW200946541A (en) 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
RU2630577C2 (en) 2008-12-04 2017-09-11 Чунси ЮЙ Compositions of intensive penetration and their application
CN111012914A (en) 2012-05-16 2020-04-17 苏州泰飞尔医药有限公司 High penetration prodrug compositions and pharmaceutical compositions for treating pulmonary diseases
CN102964250A (en) * 2012-11-19 2013-03-13 吉林大学 Flurbiprofen eugenol ester medical compound and preparation and preparation method thereof
US9187454B2 (en) * 2013-03-13 2015-11-17 Boston Biomedical, Inc. Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof
US9227962B2 (en) 2013-03-13 2016-01-05 Boston Biomedical, Inc. Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2190087C (en) * 1994-05-10 2005-08-02 Piero Del Soldato Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
IT1308633B1 (en) * 1999-03-02 2002-01-09 Nicox Sa NITROSSIDERIVATI.
IT1311924B1 (en) * 1999-04-13 2002-03-20 Nicox Sa PHARMACEUTICAL COMPOUNDS.
IT1311923B1 (en) * 1999-04-13 2002-03-20 Nicox Sa PHARMACEUTICAL COMPOUNDS.
IT1319202B1 (en) * 2000-10-12 2003-09-26 Nicox Sa DRUGS FOR INFLAMMATORY-BASED DISEASES.
ITMI20011240A1 (en) * 2001-06-13 2002-12-13 Nicox Sa DRUGS FOR VASCULOPATHIES

Also Published As

Publication number Publication date
WO2004000300A1 (en) 2003-12-31
ITMI20021399A1 (en) 2003-12-29
AU2003238042A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
CY2015028I2 (en) AN N-ACYLOSPHIGOSINE GLYCOSYLOTRANSFERASE INHIBITOR
ITMI20021399A0 (en) CYCLOXYGENASE INHIBITORS 2
DE60234125D1 (en) E INHIBITORS
DE60320933D1 (en) RHO-KINASE INHIBITORS
DK1505963T3 (en) Hepatitis C Inhibitors
NO20034308D0 (en) New tyrokinase inhibitors
NO20034042D0 (en) Metalloproteinases inhibitors
ATE308544T1 (en) N-SUBSTITUIETE HETEROARYLOXY-ARYL-SPIRO-PYRIMIDINE-2,4,6-TRION METALLOPROTEINASE INHIBITORS
DE602004018837D1 (en) PTIDASE-IV INHIBITORS
ATE304015T1 (en) TRIARYL-OXY-ARYL-SPIRO-PYRIMIDINE-2, 4, 6-TRION METALLOPROTEINASE INHIBITORS
NO20034032L (en) Metalloproteinases inhibitors
ATE402700T1 (en) GLYCINAMIDE DERIVATIVES AS RAF-KINASE INHIBITORS
DK1501804T3 (en) Isoquinoline derivative MAO-B inhibitors
ATA1572002A (en) MANAGEMENTSPLEISSKASSETTE
DE60324018D1 (en) AGONIST
DE60229669D1 (en) X-2 INHIBITORS
ATE396170T1 (en) MONOAMINE INTAKE INHIBITOR
ATE373648T1 (en) NF-KAPPAB INHIBITORS
DE50206507D1 (en) CONTACT SCREW
DE60307471D1 (en) INHIBITION
DE60315020D1 (en) (2S) -2-ETHYLPHENYLPROPIONSÄUREDERIVAT
ITMI20021327A1 (en) NEW OSSIALCHILPIPERAZINE
AT5889U3 (en) BRENNHOLZSPLEISSER
DE50310191D1 (en) cache
ATA15092002A (en) BECKENRÄUMER